A new study led by Columbia’s Mathew Maurer found that tafamidis reduced deaths from transthyretin amyloid cardiomyopathy, a type of heart failure.
Aspirin does not increase the risk of hospitalization or death in patients taking ACE inhibitors or ARBs for heart failure, Columbia researchers have found.
Using a noninvasive test developed at Columbia, older TAVR patients with an unusual heart failure pattern were found to have cardiac amyloidosis.
Smoking counteracts the effect of a gene that normally protects against heart disease, according to a new study.
Columbia University names cardiology researchers Muredach P. Reilly and Marwah Abdalla 2017 Marjorie and Lewis Katz Scholars.
Researchers have found that only 16 percent of heart attack survivors get the recommended amount of physical activity in the weeks after hospitalization.